Published October 29, 2024
| Version v1
Journal article
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism
Creators
- Rondeau, Vincent
- Kalogeraki, Maria
- Roland, Lilian
- Nader, Zeina Abou
- Gourhand, Vanessa
- Bonaud, Amélie
- Lemos, Julia
- Khamyath, Mélanie
- Moulin, Clémentine
- Schell, Bérénice
- Delord, Marc
- Bidaut, Ghislain
- Lecourt, Séverine
- Freitas, Christelle
- Anginot, Adrienne
- Mazure, Nathalie M
- Mcdermott, David
- Parietti, Véronique
- Setterblad, Niclas
- Dulphy, Nicolas
- Bachelerie, Françoise
- Aurrand-Lions, Michel
- Stockholm, Daniel
- Lobry, Camille
- Murphy, Philip
- Espéli, Marion
- Mancini, Stéphane
- Balabanian, Karl
Contributors
Others:
- Ecotaxie, microenvironnement et développement lymphocytaire (EMily (UMR_S_1160 / U1160)) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
- Institut Paoli-Calmettes (IPC) ; Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)
- Dynamique des cellules tumorales (TCD) ; Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
- Centre méditerranéen de médecine moléculaire (C3M) ; Université Nice Sophia Antipolis (1965 - 2019) (UNS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Côte d'Azur (UniCA)
- National Institute of Allergy and Infectious Diseases [Bethesda] (NIAID-NIH) ; National Institutes of Health [Bethesda, MD, USA] (NIH)
- Hopital Saint-Louis [AP-HP] (AP-HP) ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
- Inflammation, microbiome, immunosurveillance (MI2) ; Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
- Centre de Recherche Saint-Antoine (CRSA) ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
- Génomes, biologie cellulaire et thérapeutiques (GenCellDis (U944 / UMR7212)) ; Collège de France (CdF (institution))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
- Microenvironment and B-cells: Immunopathology,Cell Differentiation, and Cancer (MOBIDIC) ; Université de Rennes (UR)-Etablissement français du sang [Rennes] (EFS Bretagne)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Seventh Framework Programme: FP7/2007-2013NHLBI Division of Intramural ResearchFP7 People: FP7/2007-2013FP7 People: PCOFUND-GA-2013-609102Agence Nationale de la Recherche: ANR-19-CE15-0019-01Agence Nationale de la Recherche: ANR-17-CE14-0019Fondation pour la Recherche Médicale: EQU202203014627Institut National Du Cancer: PRT-K 2017Fondation pour la Recherche Médicale: FRM 2022Institut National Du Cancer: PRT-K 2017Fondation pour la Recherche Médicale: FRM 2022Fondation pour la Recherche Médicale: EQU202203014627European Union: PCOFUND-GA-2013-609102
- ANR-19-CE15-0019,PC-SEC,Impact des SNARE sur la biologie des plasmocytes(2019)
- ANR-17-CE14-0019,OSTEOVALYMPH,Autocrinie et paracrinie de l'axe de signalisation CXCL12/CXCR4-CXCR7 dans la niche ostéo-vasculaire: impact sur la spécification et l'engagement lymphoïde des cellules souches hématopoïétiques(2017)
- European Project: 609102,EC:FP7:PEOPLE,FP7-PEOPLE-2013-COFUND,PRESTIGE(2014)
Description
Both cell-intrinsic and niche-derived, cell-extrinsic cues drive the specification of hematopoietic multipotent progenitors (MPPs) in the bone marrow, which comprise multipotent MPP1 cells and lineage-restricted MPP2, MPP3, and MPP4 subsets. Patients with WHIM syndrome, a rare congenital immunodeficiency caused by mutations that prevent desensitization of the chemokine receptor CXCR4, have an excess of myeloid cells in the bone marrow. Here, we investigated the effects of increased CXCR4 signaling on the localization and fate of MPPs. Knock-in mice bearing a WHIM syndrome–associated CXCR4 mutation ( CXCR4 1013 ) phenocopied the myeloid skewing of bone marrow in patients. Whereas MPP4 cells in wild-type mice differentiated into lymphoid cells, MPP4s in CXCR4 1013 knock-in mice differentiated into myeloid cells. This myeloid rewiring of MPP4s in CXCR4 1013 knock-in mice was associated with enhanced signaling mediated by the kinase mTOR and increased oxidative phosphorylation (OXPHOS). MPP4s also localized further from arterioles in the bone marrow of knock-in mice compared with wild-type mice, suggesting that the loss of extrinsic cues from the perivascular niche may also contribute to their myeloid skewing. Chronic treatment with the CXCR4 antagonist AMD3100 or the mTOR inhibitor rapamycin restored the lymphoid potential of MPP4s in knock-in mice. Thus, CXCR4 desensitization drives the lymphoid potential of MPP4 cells by dampening the mTOR-dependent metabolic changes that promote myeloid differentiation.
Abstract
International audienceAdditional details
Identifiers
- URL
- https://hal.science/hal-04786079
- URN
- urn:oai:HAL:hal-04786079v1
Origin repository
- Origin repository
- UNICA